AbbVie, Apogee Therapeutics filed HSR July 6, setting up Aug. 5 expiration
MLex Summary: AbbVie and Apogee Therapeutics each filed the required Hart-Scott-Rodino Act notification paperwork on July 6 for their merger, starting a 30-day waiting period for the US Federal Trade Commission and...To view the full article, register now.
Already a subscriber? Click here to view full article